John R. Jacobsen - 14 Apr 2022 Form 4 Insider Report for DICE Therapeutics, Inc.

Role
CSO
Signature
/s/ Scott Robertson as attorney-in-fact for John R. Jacobsen
Issuer symbol
N/A
Transactions as of
14 Apr 2022
Net transactions value
$0
Form type
4
Filing time
19 Apr 2022, 18:46:44 UTC
Previous filing
14 Sep 2021
Next filing
31 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DICE Stock Option (right to buy) Award $0 +154,250 $0.000000 154,250 14 Apr 2022 Common Stock 154,250 $19.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the total shares monthly, beginning January 1, 2022, until such time as the option is 100% vested on the four-year anniversary, subject to the Reporting Holder's continued service to the Registrant.